Home >> Pharmaceuticals >> Food & Beverage >>

Pharmicell Co., Ltd. - Product Pipeline Review - 2015

Published: Aug-2015 | Format: PDF | Global Markets Direct | Number of pages: 30 | Code: MRS - 35142

Pharmicell Co., Ltd. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Pharmicell Co., Ltd. - Product Pipeline Review - 2015’, provides an overview of the Pharmicell Co., Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Pharmicell Co., Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Pharmicell Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Pharmicell Co., Ltd.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Pharmicell Co., Ltd.’s pipeline products

Reasons to buy

- Evaluate Pharmicell Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Pharmicell Co., Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Pharmicell Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Pharmicell Co., Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Pharmicell Co., Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Pharmicell Co., Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Pharmicell Co., Ltd. Snapshot 5
Pharmicell Co., Ltd. Overview 5
Key Information 5
Key Facts 5
Pharmicell Co., Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Pharmicell Co., Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pharmicell Co., Ltd. - Pipeline Products Glance 10
Pharmicell Co., Ltd. - Late Stage Pipeline Products 10
Phase III Products/Combination Treatment Modalities 10
Pharmicell Co., Ltd. - Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
Pharmicell Co., Ltd. - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Pharmicell Co., Ltd. - Drug Profiles 14
Cerecellgram-Stroke 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Cerecellgram-Spine 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Livercellgram 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Cerecellgram for Parkinson's Disease 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Immunocellgram for Cancer 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Immunocellgram for Graft Versus Host Disease 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Cellgram for Severe Lower Limb Ischemia 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Immpocellgram 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Cellgram for Severe Hard of Hearing 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Lungcellgram 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Pharmicell Co., Ltd. - Pipeline Analysis 24
Pharmicell Co., Ltd. - Pipeline Products by Route of Administration 24
Pharmicell Co., Ltd. - Pipeline Products by Molecule Type 25
Pharmicell Co., Ltd. - Recent Pipeline Updates 26
Pharmicell Co., Ltd. - Dormant Projects 27
Pharmicell Co., Ltd. - Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Appendix 29
Methodology 29
Coverage 29
Secondary Research 29
Primary Research 29
Expert Panel Validation 29
Contact Us 29
Disclaimer 30

List of Tables
Pharmicell Co., Ltd., Key Information 5
Pharmicell Co., Ltd., Key Facts 5
Pharmicell Co., Ltd. - Pipeline by Indication, 2015 7
Pharmicell Co., Ltd. - Pipeline by Stage of Development, 2015 8
Pharmicell Co., Ltd. - Monotherapy Products in Pipeline, 2015 9
Pharmicell Co., Ltd. - Phase III, 2015 10
Pharmicell Co., Ltd. - Phase II, 2015 11
Pharmicell Co., Ltd. - Phase I, 2015 12
Pharmicell Co., Ltd. - Preclinical, 2015 13
Pharmicell Co., Ltd. - Pipeline by Route of Administration, 2015 24
Pharmicell Co., Ltd. - Pipeline by Molecule Type, 2015 25
Pharmicell Co., Ltd. - Recent Pipeline Updates, 2015 26
Pharmicell Co., Ltd. - Dormant Developmental Projects,2015 27
Pharmicell Co., Ltd., Other Locations 28

List of Figures
Pharmicell Co., Ltd. - Pipeline by Top 10 Indication, 2015 7
Pharmicell Co., Ltd. - Pipeline by Stage of Development, 2015 8
Pharmicell Co., Ltd. - Monotherapy Products in Pipeline, 2015 9
Pharmicell Co., Ltd. - Pipeline by Top 10 Route of Administration, 2015 24
Pharmicell Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015 25

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing